Temperature Controlled Pharmaceutical Containers Global Market Report 2024

The global temperature controlled pharmaceutical containers market has grown rapidly in recent years. It will grow from $5.53 billion in 2023 to $6.11 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The growth observed in the historical period can be attributed to several factors, including the increased transportation of pharmaceutical products, adherence to regulatory compliance standards, globalization leading to more intricate pharmaceutical supply chains, the rising complexity of pharmaceutical products, and a heightened focus on ensuring patient safety within the pharmaceutical industry.

The global temperature controlled pharmaceutical containers market is expected to see rapid growth in the next few years. It will grow to $9.38 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. Anticipated growth in the forecast period can be attributed to several key factors, including the expanding biopharmaceutical market, a heightened focus on last-mile delivery solutions, increased regulatory stringency in pharmaceutical transportation, a rise in personalized medicine practices, and global health emergencies leading to heightened vaccination needs. Major trends expected in the forecast period encompass advancements in cold chain technologies aimed at improving temperature-controlled logistics, the continued globalization of pharmaceutical supply chains to meet growing demand, utilization of advanced insulation and thermal barrier materials to enhance product protection, and an increase in outsourcing of cold chain logistics services within the pharmaceutical industry.

The temperature-controlled pharmaceutical containers market is experiencing increased demand, primarily driven by rising vaccine sales. Vaccines, crucial for bolstering the body's immune defenses against diseases, require careful storage and transportation in temperature-controlled containers to ensure their safety and efficacy. For example, Sanofi S.A., a France-based biopharmaceutical company, reported a 6.8% increase in net revenue for the vaccines segment in 2021, reaching USD 6,197.96 million. The growth in vaccine sales is expected to be a key driver for the temperature-controlled pharmaceutical container market.

The growth of the temperature-controlled pharmaceutical container market is further propelled by the increasing prevalence of chronic diseases. Chronic illnesses, lasting a year or longer and requiring ongoing medical care, are becoming more prevalent. Conditions such as heart disease, cancer, obesity, and diabetes necessitate the safe transport and storage of temperature-sensitive medications. Temperature-controlled pharmaceutical containers play a crucial role in preserving the efficacy of these medications, ensuring therapeutic integrity, and supporting consistent treatment for patients with chronic conditions. The National Center for Biotechnology Information (NCBI) projects a significant surge in the number of individuals aged 50 years and older with at least one chronic illness by the year 2050, reaching 142.66 million. This increasing prevalence of chronic diseases is a significant factor driving the growth of the temperature-controlled pharmaceutical container market.

Innovation and the development of novel packaging solutions are key trends in the temperature-controlled pharmaceutical containers market. Major players in this sector are focusing on creating innovative packaging solutions to sustain their market presence. For instance, Tower Cold Chain, a UK-based company specializing in packaging and container manufacturing, introduced the KTEvolution container in March 2022. This container, designed for the transportation of pharmaceutical, life sciences, and biomedical products under temperature control, incorporates compact vacuum-insulated panels with phase-change technology. This innovation ensures long-term thermal protection without the need for frequent human intervention. The KTEvolution container features a lightweight webbing system and utilizes minimal fasteners and fittings to achieve efficiency in temperature control and transport.

Major companies in the temperature-controlled pharmaceutical container market are placing increased emphasis on introducing advanced thermal packaging solutions as part of their strategy to gain a competitive advantage. Notable examples include the Celsure XL Pallet Shipper series and the Celsure VIP Multi-Use Parcel Shipper series, designed to maintain the temperature integrity of sensitive products during transportation. For instance, PLUSS Advanced Technologies, an India-based company, unveiled two new temperature-controlled packaging solutions in September 2023, the Celsure XL Pallet Shipper series and the Celsure VIP Multi-Use Parcel Shipper series. These innovative products are specifically engineered to ensure temperature consistency across diverse geographies and seasons, addressing the complex challenges encountered by the pharmaceutical supply chain. This strategic move allows PLUSS Advanced Technologies to offer state-of-the-art solutions catering to the evolving needs of the industry.

In a significant development in December 2021, CSafe Global, a US-based company specializing in thermal shipping solutions, acquired Softbox Systems for an undisclosed amount. This strategic acquisition positions CSafe Global as a leading provider for the cold chain delivery of expensive and temperature-sensitive pharmaceutical medicines. Softbox Systems, based in the UK, is recognized for providing passive temperature-controlled packaging solutions tailored for the pharmaceutical, life sciences, and cold chain logistics sectors. The acquisition enhances CSafe Global's capabilities and market presence, allowing it to offer comprehensive solutions for maintaining the integrity of temperature-sensitive pharmaceuticals during transit.

Major companies operating in the temperature controlled pharmaceutical containers market report are Peli BioThermal LLC, American Aerogel Corporation, AmerisourceBergen Corporation, Cold Chain Technologies Inc., Envirotainer Ltd., FedEx Corporation, Inmark LLC, Intelsius Ltd., Snyder Industries LLC, Sofrigam SAS, Sonoco Company, Tempack Packaging Solutions SL, United Parcel Service of America Inc., Va-Q-tec AG, Pelican BioThermal LLC, Softbox Systems Ltd., Cryopak Industries Inc., DHL International GmbH, Kuehne + Nagel International AG, World Courier Inc., Kalibox SA, Kodiak Technologies, Mesa Laboratories Inc., NOVA Chemicals Corporation, Sorba-Freeze Ltd., Termo-Kont MK LLC, Thermal Shipping Solutions, Thomas EMS, The Wool Packaging Company, Zarges GmbH, AeroSafe Global Inc., B Medical Systems SàRL, Croda International, Insulated Packaging Corp.

North America was the largest region in the temperature controlled pharmaceutical containers market share in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the temperature controlled pharmaceutical containers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the temperature controlled pharmaceutical containers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Temperature-controlled pharmaceutical containers feature two primary types of controls such as active and passive. Active shipping containers, often leased, are equipped with modern temperature controls powered by electricity and/or batteries. These containers come in various forms such as chest-style and upright-style containers, tailored to store vaccines, drugs (IV), samples (blood, biopsy, etc.), reagents, and genetic materials. They are extensively used by pharmaceutical companies and in clinical trial settings.

This report provides temperature controlled pharmaceutical containers market statistics, including temperature controlled pharmaceutical containers industry global market size, regional shares, competitors with temperature controlled pharmaceutical containers market share, detailed temperature controlled pharmaceutical containers market segments, market trends, and opportunities, and any further data you may need to thrive in the temperature controlled pharmaceutical containers industry. This temperature controlled pharmaceutical containers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The temperature controlled pharmaceutical containers market consists of sales of single-use, and reusable temperature-controlled pharmaceutical containers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.